Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can telehealth replace In-Person cardiac rehab? large study aims to find out

NCT ID NCT05933083

Disease control Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Sep 03, 2026 · Updated 3 times

Summary

This study compares two ways of delivering cardiac rehabilitation: in-person sessions and telehealth sessions. Cardiac rehab includes exercise training, health education, and counseling for people with heart conditions like heart attack, heart failure, or after heart surgery. The study will enroll 516 adults and measure changes in walking distance and quality of life over 12 months. The goal is to see if telehealth works as well as in-person care and which patients benefit most from each approach.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
cardiac rehabilitation (exercise training, health education, and counseling) delivered either in-person or via telehealth
What this could lead to
If successful, this could show that telehealth cardiac rehab is as effective as in-person sessions, making it easier for more heart patients to participate.
What could go wrong
This is a comparative effectiveness study, not a test of a new treatment. Results may show differences in outcomes for certain groups, but won't prove a cure or major breakthrough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 516 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2023

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age 18 or older 2. Eligible for cardiac rehabilitation 1. Diagnosis within 1 year prior to consent * Myocardial infarction * Percutaneous coronary intervention * Coronary artery bypass * Heart valve repair or replacement * Heart transplant 2. Chronic stable angina, or 3. Chronic systolic heart failure (ejection fraction ≤ 35%) 4. Referred to cardiac rehabilitation by a doctor or advanced practice provider for another indication that is covered by the participant's insurance, such as heart failure with preserved ejection fraction or aortic surgery. 3. Willing to be randomized to in-person or telehealth cardiac rehabilitation 4. Able to communicate in English or Spanish Exclusion Criteria: 1. Unstable arrhythmias which may make unmonitored exercise unsafe (e.g., history of ventricular tachycardia not on medical therapy and without an implantable cardioverter defibrillator) 2. Unsafe for patient to participate in the opinion of the investigator 3. Hospice 4. Unable to consent for self

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Angina (stable) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Angina, Stable coronary artery disorder heart valve disorder intermediate coronary syndrome myocardial infarction systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Angina (stable) Coronary artery disease Heart failure, systolic Heart transplant Heart valve diseases Myocardial infarction

Contacts and locations

Locations

  • Denver Health

    Denver, Colorado, 80204, United States

  • Johns Hopkins University Medical Center

    Baltimore, Maryland, 21287, United States

  • University of California, San Francisco

    San Francisco, California, 94143, United States

  • University of Michigan

    Ann Arbor, Michigan, 48105, United States

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, 15232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.